Although some studies have shown that the presence of C-MYC aberrations was significantly associated with shorter survival in DLBCL [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], other studies failed to show such an association between C-MYC and worse prognosis [25], [26], [27], [28], [29], [30]. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.